Study of Daylight Photodynamic Therapy With Aminolevulinic Acid for Actinic Keratoses

Summary

Photodynamic therapy is an effective treatment for actinic keratoses. In the United States topical aminolevulinic acid (ALA) is approved as a photosensitizing agent for this treatment, and it has traditionally been activated with the use of an in-office artificial light source. This clinical trial seeks to measure the safety and efficacy of using natural sunlight to activate the ALA.

Timeline

Start

2015-04

Primary completion

2017-02

Completion

2017-07

Drugs

Indications